EDAP to Participate in the 2024 Jefferies London Healthcare Conference
EDAP 11.06.2024
Date of Upcoming Event:2024-11-19
Name of Upcoming Event:Jefferies London Healthcare Conference
About Gravity Analytica
LYON, France, November 6, 2024 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, announced that Ryan Rhodes, Chief Executive Officer, is scheduled to present and host 1x1 investor meetings at the Jefferies London Healthcare Conference, which is being held November 19-21, 2024.
Date: Tuesday, November 19
Time: 8:30-8:55 AM GMT
Location: The Waldorf Hilton London
Webcast:LINK
The live and archived webcast of the presentation can be accessed in the Investors section of the Company’s websitehere.
About EDAP TMS SAA recognized leader in the global therapeutic ultrasound market, EDAP TMS develops, manufactures, promotes and distributes worldwide minimally invasive medical devices for various pathologies using ultrasound technology. By combining the latest technologies in imaging and treatment modalities in its complete range of Robotic HIFU devices, EDAP TMS introduced the Focal One®in Europe and in the U.S. as an answer to all requirements for ideal prostate tissue ablation. With the addition of the ExactVuTM Micro-Ultrasound device, EDAP TMS is now the only company offering a complete solution from diagnostics to focal treatment of Prostate Cancer. EDAP TMS also produces and distributes other medical equipment including the Sonolith®i-move lithotripter and lasers for the treatment of urinary tract stones using extra-corporeal shockwave lithotripsy (ESWL). For more information on the Company, please visithttp://www.edap-tms.com,us.hifu-prostate.comandwww.focalone.com.
Company ContactBlandine ConfortInvestor Relations / Legal AffairsEDAP TMS SA+33 4 72 15 31 50bconfort@edap-tms.com
Investor ContactJohn FrauncesLifeSci Advisors, LLC(917) 355-2395jfraunces@lifesciadvisors.com